Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Wujak (Giessen, Germany), T. Wilke (Giessen, Germany), A. Weiss (Giessen, Germany), M. Brosien (Giessen, Germany), C. Wu (Giessen, Germany), R. Schermuly (Giessen, Germany), H. Ghofrani (Giessen, Germany), W. Seeger (Giessen, Germany), F. Grimminger (Giessen, Germany), O. Pak (Giessen, Germany), N. Weissmann (Giessen, Germany). Role of adenylate kinase 4 as a new metabolic regulator of pulmonary artery smooth muscle cells under hypoxia. 5044

Member's Comments

No comment yet.

Related content which might interest you: Endothelin-1 downregulates BMP signaling in pulmonary artery smooth muscle cells Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012 Endothelin-1 inhibits TASK-1 in human pulmonary artery smooth muscle cells via phospholipase C-diacylglycerol-protein kinase C-pathway Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension Year: 2008 PKC inhibits BKCa channel activity in pulmonary arterial smooth muscle cells through multiple signaling pathways Source: Eur Respir J 2006; 28: Suppl. 50, 159s Year: 2006 Bosentan stimulates the expression of cell cycle inhibitor p27(kip1) in pulmonary artery smooth muscle cells (PASMC) Source: Annual Congress 2007 - Animal and ex vivo models of airway inflammation Year: 2007 Hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: possible mechanisms Source: Eur Respir J 2004; 24: Suppl. 48, 561s Year: 2004 Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells - role of hypoxia-inducible transcription factors Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001 Proliferative hypoxic response of pulmonary artery smooth muscle cells: the fibroblasts role Source: Eur Respir J 2007; 30: Suppl. 51, 510s Year: 2007 miR 16 modulates human pulmonary artery smooth muscle cell phenotype Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology Year: 2012 Antiproliferative effects of drugs affecting different signalling pathways on rat and human pulmonary artery smooth muscle cells Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Mir-17 modulates smooth muscle cell markers, apoptosis and BMPR-II levels in human pulmonary artery smooth muscle cells Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Sildenafil modulates PDGF and Angiotensin II induced migration and proliferation in human pulmonary artery smooth muscle cells (PA-SMC) Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002 MAP kinase phosphatase 1 mediates glucocorticoid inhibition of CD38 expression in human airway smooth muscle Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 Role of Ca2+-dependent protein kinases and protein phosphatase in the effect of urotensin II on the rat airway smooth muscle cells proliferation Source: Eur Respir J 2004; 24: Suppl. 48, 227s Year: 2004 Mitophagy plays an important role in hypoxia-induced pulmonary artery smooth muscle cell proliferation Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 Phosphodiesterase-type 3 inhibitor potentiates cAMP generation and antiproliferative effects of treprostinil in pulmonary arterial smooth muscle cells from patients with pulmonary hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Increased p130Cas activity induces smooth muscle cell proliferation and migration in idiopathic pulmonary arterial hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 The effect of ASK1 inhibition on hypoxia-induced pulmonary artery fibroblast activation and associated paracrine effects on vascular smooth muscle cells Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 PDGF and Src tyrosine kinases in pulmonary arterial smooth muscle cells: Effects of dasatinib and nilotinib on pulmonary vascular remodeling Source: Annual Congress 2011 - Treatments for pulmonary hypertension in human and experimental models Year: 2011 Caspase-1 triggers smooth muscle cell proliferation in hypoxic pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 LSC - 2018 - Pulmonary vascular remodeling mediated by ADORA2B in pulmonary artery smooth muscle cells Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018